Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-28T13:38:12.688Z Has data issue: false hasContentIssue false
  • English
  • Français

Alcohol consumption and cardiovascular risk: a descriptive study in a psychiatric short stay unit

Published online by Cambridge University Press:  19 July 2023

C. González Navarro ,
I. Alonso Salas ,
L. Morado San segundo ,
A. López Fariña ,
A. Bilbao Idarraga ,
U. López Puentes ,
B. Samsó Martínez ,
R. F. Lopez Brokate ,
T. Ruiz de Azua Aspizua  and
E. M. Garnica de Cos
...Show all authors
C. González Navarro*
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
I. Alonso Salas
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
L. Morado San segundo
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
A. López Fariña
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
A. Bilbao Idarraga
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
U. López Puentes
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
B. Samsó Martínez
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
R. F. Lopez Brokate
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
T. Ruiz de Azua Aspizua
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
E. M. Garnica de Cos
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
U. Ortega Pozas
Affiliation:
RED DE SALUD MENTAL DE BIZKAIA, ZAMUDIO, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Patients with mental disorders have a decreased life expectancy, being the main reason the cardiovascular disease. An important proportion of patients present a comorbid drug consumption. Amongst drugs, alcohol is the most frequent, and it is associated with a higher cardiovascular risk. The metabolic syndrome is one of the most employed tools to assess cardiovascular risk.

Objectives

- To describe the demographic characteristics of the patients with an active alcohol consumption that were admitted to the hospital during the period of study.

  • - To describe the prevalence of metabolic syndrome in the sample, according to the Adult Treatment Panel III (ATP-III) criteria.

Methods

Retrospective observational study of three months duration. Data was collected from all patients admitted to the hospital during the period of study, with no specific exclusion criteria. Descriptive statistics were performed.

Results

During the period of study 172 patients were admitted to the hospital (56.4% women and 43.6% men). A 44.8% presented alcohol consumption (25% sporadically, 6.4% weekly and 13.4% daily). Amongst women, 1% presented daily and 1% weekly consumption. Amongst men, 21.3% presented daily and 5.3% weekly consumption.

The prevalence of metabolic syndrome in the study sample was 29.11%. In the alcohol consumption group, the prevalence was 24.7% and differed according to the pattern of consumption: 43.5% in the daily consumption group, 27.3% in the weekly and 14% in the sporadically consumption group.

Conclusions

On the one hand, in the sample of study a higher percentage of men present an active alcohol consumption, compared to women. It is remarkable the high percentage of daily alcohol consumption amongst men in our sample.

On the other hand, the prevalence of metabolic syndrome in our sample is similar to the one found in scientific literature regarding patients with mental disorders. It is noteworthy in our sample the increased prevalence of metabolic syndrome found in patients with a daily alcohol consumption, and a decreased prevalence in those with a sporadic pattern.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S754
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.